And it depends on you how soon it will be developed
Equities have greeted 2018 with a bang, but none more so than Korean pharmaceutical maker Celltrion Inc., which has piled on about 9 trillion won ($8.4 billion) of market value in just seven days.
On Wednesday, Warren Buffett's Berkshire Hathaway disclosed a $358 million stake in Israeli generic drug company Teva Pharmaceutical Industries.
Scientists at Wake Forest Institute for Regenerative Medicine (WFIRM) have developed the most sophisticated mini-livers to date. These organoids can potentially help scientists better understand certain congenital liver diseases as well as speed up efforts to create liver tissue in the lab for transplantation into patients.
Siemens is planning to list its 40 billion euro ($47.94 billion) healthcare unit Healthineers in March, two people close to the matter said, as the group hopes to execute the deal while market conditions are favourable.